WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H464509
CAS#: unknown
Description: RR-Src is a synthetic peptide substrate that corresponds to the sequence in Src surrounding the tyrosine subject to phosphorylation. It is a substrate for EGF-mediated tyrosine phosphorylation. RR-Src inhibits IL-2-induced proliferation of cytotoxic T cells.
Hodoodo Cat#: H464509
Name: RR-Src TFA
CAS#: unknown
Chemical Formula: C66H107F3N22O23
Exact Mass: 0.00
Molecular Weight: 1,633.708
Elemental Analysis: C, 48.52; H, 6.60; F, 3.49; N, 18.86; O, 22.52
Synonym: RR-Src TFA; RRSrc TFA; RR Src TFA; Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly; RRLIEDAEYAARG; Src-Peptide; Src Peptide;
IUPAC/Chemical Name: (5S,8S,11S,14S,17S,20S,23S,26S)-17-(2-carboxyethyl)-23-(carboxymethyl)-26-((6S,9S,12S,15S)-1,6-diamino-15-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-12-isobutyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-amido)-5-(3-guanidinopropyl)-14-(4-hydroxybenzyl)-8,11,20-trimethyl-4,7,10,13,16,19,22,25-octaoxo-3,6,9,12,15,18,21,24-octaazanonacosanedioic acid compound with 2,2,2-trifluoroacetic acid (1:1)
InChi Key: OSZFOKWAQDVJJB-YQYPCEDLSA-N
InChi Code: InChI=1S/C64H106N22O21.C2HF3O2/c1-8-31(4)49(86-60(106)42(26-30(2)3)83-55(101)39(14-11-25-74-64(70)71)81-53(99)37(65)12-9-23-72-62(66)67)61(107)82-41(20-22-46(90)91)57(103)85-44(28-47(92)93)59(105)78-34(7)52(98)80-40(19-21-45(88)89)56(102)84-43(27-35-15-17-36(87)18-16-35)58(104)77-32(5)50(96)76-33(6)51(97)79-38(13-10-24-73-63(68)69)54(100)75-29-48(94)95;3-2(4,5)1(6)7/h15-18,30-34,37-44,49,87H,8-14,19-29,65H2,1-7H3,(H,75,100)(H,76,96)(H,77,104)(H,78,105)(H,79,97)(H,80,98)(H,81,99)(H,82,107)(H,83,101)(H,84,102)(H,85,103)(H,86,106)(H,88,89)(H,90,91)(H,92,93)(H,94,95)(H4,66,67,72)(H4,68,69,73)(H4,70,71,74);(H,6,7)/t31-,32-,33-,34-,37-,38-,39-,40-,41-,42-,43-,44-,49-;/m0./s1
SMILES Code: OC1=CC=C(C[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(N)=N)N)=O)CCCNC(N)=N)=O)CC(C)C)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CC(O)=O)=O)C)=O)CCC(O)=O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(O)=O)=O)CCCNC(N)=N)=O)C)=O)C)=O)C=C1.OC(C(F)(F)F)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 1.0 | 0.61 | |
| PBS (pH 7.2) | 10.0 | 6.00 |
The following data is based on the product molecular weight 1,633.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Hernández-Ramírez VI, Anaya-Ruiz M, Rios A, Talamás-Rohana P. Entamoeba histolytica: tyrosine kinase activity induced by fibronectin through the beta1-integrin-like molecule. Exp Parasitol. 2000 Jun;95(2):85-95. doi: 10.1006/expr.2000.4522. PMID: 10910709.
2: Shen SS, Kinsey WH, Lee SJ. Protein tyrosine kinase-dependent release of intracellular calcium in the sea urchin egg. Dev Growth Differ. 1999 Jun;41(3):345-55. doi: 10.1046/j.1440-169x.1999.413436.x. PMID: 10400396.
3: Leet CS, Vincan E, Thomas RJ, Phillips WA. Lipopolysaccharide-induced priming of the human neutrophil is not associated with a change in phosphotyrosine phosphatase activity. Int J Biochem Cell Biol. 1999 May;31(5):585-93. doi: 10.1016/s1357-2725(99)00008-4. PMID: 10399319.
4: Lim KL, Kolatkar PR, Ng KP, Ng CH, Pallen CJ. Interconversion of the kinetic identities of the tandem catalytic domains of receptor-like protein-tyrosine phosphatase PTPalpha by two point mutations is synergistic and substrate- dependent. J Biol Chem. 1998 Oct 30;273(44):28986-93. doi: 10.1074/jbc.273.44.28986. PMID: 9786903.
5: Islas-Flores I I, Oropeza C, Hernandez-Sotomayor SM. Protein phosphorylation during coconut zygotic embryo development. Plant Physiol. 1998 Sep;118(1):257-63. doi: 10.1104/pp.118.1.257. PMID: 9733545; PMCID: PMC34863.
6: Ashizawa K, Higashio M, Tsuzuki Y. Effects of tyrosine kinase inhibitor on the motility and ATP concentrations of fowl spermatozoa. Mol Reprod Dev. 1998 Feb;49(2):196-202. doi: 10.1002/(SICI)1098-2795(199802)49:2<196::AID- MRD10>3.0.CO;2-X. PMID: 9444662.
7: Rodríguez-Zapata LC, Hernández-Sotomayor SM. Evidence of protein-tyrosine kinase activity in Catharanthus roseus roots transformed by Agrobacterium rhizogenes. Planta. 1998 Jan;204(1):70-7. doi: 10.1007/s004250050231. PMID: 9443385.
8: Olsen H, Enan E, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanism of action to reduce lipoprotein lipase activity in the 3T3-L1 preadipocyte cell line. J Biochem Mol Toxicol. 1998;12(1):29-39. doi: 10.1002/(sici)1099-0461(1998)12:1<29::aid-jbt5>3.0.co;2-r. PMID: 9414485.
9: Bassal S, Liu YS, Thomas RJ, Phillips WA. Phosphotyrosine phosphatase activity in the macrophage is enhanced by lipopolysaccharide, tumor necrosis factor alpha, and granulocyte/macrophage-colony stimulating factor: correlation with priming of the respiratory burst. Biochim Biophys Acta. 1997 Mar 1;1355(3):343-52. doi: 10.1016/s0167-4889(96)00149-8. PMID: 9061005.
10: Chen H, Bashiardes G, Mailliet P, Commercon A, Sounigo F, Boiziau J, Parker F, Tocque B, Roques BP, Garbay C. Synthesis and biological evaluation of a series of hydroxybenzylphenylamine derivatives as inhibitors of EGF receptor- associated tyrosine kinase activity. Anticancer Drug Des. 1996 Jan;11(1):49-71. PMID: 8639248.
11: Ong KC, Khoo HE, Das NP. Tannic acid inhibits insulin-stimulated lipogenesis in rat adipose tissue and insulin receptor function in vitro. Experientia. 1995 Jun 14;51(6):577-84. doi: 10.1007/BF02128747. PMID: 7607300.
12: Lu J, Notkins AL, Lan MS. Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Commun. 1994 Oct 28;204(2):930-6. doi: 10.1006/bbrc.1994.2549. PMID: 7980563.
13: Taffs RE, Sitkovsky MV. Modulation of the effector functions of cytolytic T-lymphocytes with synthetic peptide inhibitors of protein kinases. J Pharm Sci. 1992 Jan;81(1):37-44. doi: 10.1002/jps.2600810108. PMID: 1619567.
14: Wang Y, Pallen CJ. The receptor-like protein tyrosine phosphatase HPTP alpha has two active catalytic domains with distinct substrate specificities. EMBO J. 1991 Nov;10(11):3231-7. PMID: 1915292; PMCID: PMC453047.
15: Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E, et al. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions. 1991 Jan;32(1-2):10-21. doi: 10.1007/BF01983301. PMID: 2058454.
16: Ferry G, Ernould AP, Genton A, Boutin JA. Assay of tyrosine protein kinase activity from HL-60 by high-performance liquid chromatography for specificity studies. Anal Biochem. 1990 Oct;190(1):32-8. doi: 10.1016/0003-2697(90)90129-w. PMID: 2285144.
17: Goris J, Pallen CJ, Parker PJ, Hermann J, Waterfield MD, Merlevede W. Conversion of a phosphoseryl/threonyl phosphatase into a phosphotyrosyl phosphatase. Biochem J. 1988 Dec 15;256(3):1029-34. doi: 10.1042/bj2561029. PMID: 2852001; PMCID: PMC1135519.
18: Okada M, Nakagawa H. Protein tyrosine kinase in rat brain: neonatal rat brain expresses two types of pp60c-src and a novel protein tyrosine kinase. J Biochem. 1988 Aug;104(2):297-305. doi: 10.1093/oxfordjournals.jbchem.a122461. PMID: 3141396.
19: Boonstra J, van der Saag PT, Feijen A, Bisschop A, de Laat S. Epidermal growth factor, but not nerve growth factor, stimulates tyrosine-specific protein-kinase activity in pheochromocytoma (PC12) plasma membranes. Biochimie. 1985 Oct-Nov;67(10-11):1177-83. doi: 10.1016/s0300-9084(85)80117-6. PMID: 3000461.
20: Sparks JW, Brautigan DL. Specificity of protein phosphotyrosine phosphatases. Comparison with mammalian alkaline phosphatase using polypeptide substrates. J Biol Chem. 1985 Feb 25;260(4):2042-5. PMID: 2982803.
